UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030221
Receipt number R000034508
Scientific Title Disease Management Program with Telemonitoring System in Patients with Chronic Heart Failure to Prevent Readmission :(Pilot Study)
Date of disclosure of the study information 2017/12/03
Last modified on 2017/12/21 01:14:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Disease Management Program with Telemonitoring System in Patients with Chronic Heart Failure to Prevent Readmission :(Pilot Study)

Acronym

Disease Management Program with Telemonitoring System in Patients with Chronic Heart Failure to Prevent Readmission

Scientific Title

Disease Management Program with Telemonitoring System in Patients with Chronic Heart Failure to Prevent Readmission :(Pilot Study)

Scientific Title:Acronym

Disease Management Program with Telemonitoring System in Patients with Chronic Heart Failure to Prevent Readmission

Region

Japan


Condition

Condition

chronic heart failure

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the most effective patient support method is essential to prevent aggravation and re-hospitalization due to acute exacerbation of patients with chronic heart failure. Specifically, for the patients of chronic heart failure with high severity; (1) self-management education method incorporating a remote monitoring system for self-management education by nurses and (2) self-monitoring for self-management education by nurses.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

self-efficacy(at 6,12,18,24months)
QOL(at 6,12,18,24months)
self-care behavior(at 6,12,18,24months)
readmission due to heart failure
readmission due to all cause
death
depression(at 6,12,18,24months
Patient Satisfaction

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Implementation of disease management program (self-management education and behavioral change for 6 months, and writing in self-management notebook for 12 months) and implementation of telenursing using telemonitoring system.

Interventions/Control_2

Implementation of disease management program (self-management education and behavioral change for 6 months, and writing in self-management notebook for 12 months)

Interventions/Control_3

The participants received routine medical consultations.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.being diagnosed with HF classified as New York Heart Association Class II to IV at registration, but III or IV when exacerbated
2.having at least one previous admission for HF or experienced an unplanned hospital visit with exacerbation of HF.
3. living at home(includes a discharging patient).
4. A patient who is physically and cognitively capable participating the program
5. A patient whom can receive a written consent form

Key exclusion criteria

1.severe comorbidity that require a treatment priority
2. inability to stand still to measure body weight
3. A patient who doesn't have a telephone
4. inability to communicate by telephone
5. A patient who has dementia

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiko Moriyama

Organization

Hiroshima university Graduate School of Biomedical & Health Sciences

Division name

Division of Nursing Science

Zip code


Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8553 Japan

TEL

082-257-5365

Email

morimich@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mariko Mizukawa

Organization

Hiroshima university Graduate School of Biomedical & Health Sciences

Division name

Ph.D program in Nursing Science

Zip code


Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8553 Japan

TEL

082-257-5367

Homepage URL


Email

unomariko@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University
Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

Hiroshima Prefecture Government

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
Miyoshi Medical Association Hospital, Miyoshi, Japan
JA Onomichi General Hospital, Onomichi, Japan
Chugoku Rosai Hospital, Kure, Japan

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 03 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The 18th Annual Scientific Meeting of the Japanese Heart Failure Society

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 11 Month 02 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 02 Day

Last follow-up date

2015 Year 09 Month 30 Day

Date of closure to data entry

2016 Year 09 Month 30 Day

Date trial data considered complete

2016 Year 09 Month 30 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 12 Month 01 Day

Last modified on

2017 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034508


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name